[The role of metalloproteinases in the development of primary open-angle glaucoma]

D I Svinareva1, M I Churnosov1

  • 1Belgorod State National Research University, Belgorod, Russia.

Vestnik Oftalmologii
|August 12, 2020
PubMed

Insights

Matrix metalloproteinases (MMP) play a key role in primary open-angle glaucoma (POAG) pathogenesis. MMP gene variations are linked to POAG development, affecting extracellular matrix regulation and optic nerve damage.

Area of Science:

  • Ophthalmology
  • Molecular Biology
  • Genetics

Background:

  • Extracellular matrix regulation is crucial for ocular health.
  • Matrix metalloproteinases (MMP) are key enzymes involved in matrix remodeling.
  • Dysregulation of MMPs is implicated in various eye pathologies.

Purpose of the Study:

  • To review the role of MMPs in the pathogenesis of primary open-angle glaucoma (POAG).
  • To explore the association between MMP gene polymorphisms and POAG.
  • To understand MMP involvement in ocular tissue changes relevant to glaucoma.

Main Methods:

  • Literature review of studies on MMPs and glaucoma.
  • Analysis of research on MMPs in extracellular matrix regulation.
  • Examination of genetic studies investigating MMP gene polymorphisms in POAG.

Main Results:

  • MMPs are involved in the pathogenesis of various glaucoma types.
  • MMPs contribute to decreased intraocular fluid outflow stability.
  • MMPs play a role in ganglionic apoptosis, optic disc remodeling, and lamina cribrosa changes in POAG.
  • Polymorphisms in MMP-1, MMP-2, and MMP-9 genes are associated with POAG.

Conclusions:

  • Matrix metalloproteinases are significantly implicated in the development and progression of primary open-angle glaucoma.
  • Genetic variations in MMP genes represent potential risk factors for POAG.
  • Targeting MMP activity could offer therapeutic strategies for glaucoma management.

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
865
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.1K
Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult...
3.1K
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1000